ClinicalTrials.Veeva

Menu

Association of Tumour Grade and Sex Steroid Receptor as a Prognostic Index in Breast Cancer

L

Liaquat University of Medical & Health Sciences

Status

Unknown

Conditions

Breast Cancer

Treatments

Other: No Intervention

Study type

Observational

Funder types

Other

Identifiers

NCT04707287
LUMHS/REC/-17

Details and patient eligibility

About

Null hypothesis: Histological grade of tumour bears no relation with the status of sex hormone receptors.

Alternate hypothesis: Both the histological grade of tumour and expression of sex steroid receptors are directly related to each other The investigators aim to;

  1. see the relationship of sex steroid receptors with the histological grade of breast cancer.
  2. evaluate the efficacy of steroid receptors as a prognostic factor

Full description

Breast cancer accounts for the largest number of deaths amongst the female population worldwide. It is now considered as a systemic disease even if diagnosed at an initial stage, as the clinical behaviour cannot be accurately predicted. Due to this reason, it is subjected to new dimensions of research every day. The aggressiveness of the cancer is directly proportional to the histopathological grade at the time of diagnosis. This is true with reference to the clinical stage at the time of presentation, the probability to metastasize and potential to recur. The idea of steroids receptor expression by the tumour is not new, and to evaluate their status prior to the induction of hormone therapy is a must.

The sex steroids, which are produced intratumorally, include estrogen, progesterone, and androgens. They act on their specific receptors present on the cell surface, within the cytoplasm and at the nuclear membrane. It is a measurement of these receptors that decide the potential of an individual to respond to different types of hormones like estrogen receptor blockers and aromatase inhibitors. Do the histological grade of tumour bears some relation with the status of these receptors and can investigators predict and rely just on the cellular behaviour of tumour for the purpose of prognosis is still under investigation. This study is designed to see the relationship between the histopathological grade of the tumour with the expression of sex steroid receptors. It will also try to evaluate whether these receptors bear some prognostic value or not.

Enrollment

382 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All patients diagnosed with breast cancer irrespective of age, gender and clinical stage

Exclusion criteria

  • Any patient who lost to follow up

Trial design

382 participants in 1 patient group

Breast Cancer Patients
Description:
All the patients irrespective of age, ethnicity and stage of disease will be including once the disease is confirmed after triple assessment
Treatment:
Other: No Intervention

Trial contacts and locations

2

Loading...

Central trial contact

Fazila Hashmi, FCPS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems